Table 1.
Socio-demographic, clinical, and psychosocial characteristics of breast cancer patients pre-chemotherapy.
| Characteristics | Total N (%) |
|---|---|
| Demographics | |
| Mean Age at Diagnosis, Years (SD) | 50.34 (10.68) |
| Race | |
| African-American | 67 (68) |
| White | 31 (32) |
| Marital Status | |
| Married/Living as Married | 43 (44) |
| Currently Single | 55 (56) |
| Education | |
| ≤ High School | 33 (34) |
| High school diploma or higher | 65 (66) |
| Insurance | |
| Private | 68 (70) |
| Public | 30 (30) |
| Clinical | |
| Co-morbid conditions | |
| None | 31 (32) |
| 1 or 2 | 39 (40) |
| 3 or more | 28 (28) |
| Cardiovascular comorbidities | 44 (45) |
| Endocrine or metabolic comorbidities | 23 (23) |
| Post-menopausal | |
| Yes | 44 (50) |
| No | 44 (50) |
| Cancer Stage | |
| Stage I | 22 (23) |
| Stage II | 56 (59) |
| Stage III | 17 (18) |
| HR Status | |
| HR Positive | 61 (63) |
| HR Negative | 36 (37) |
| Surgery Type | |
| Mastectomy | 60 (61) |
| Lumpectomy | 38 (39) |
| Tumor size | |
| <2cm | 38 (39) |
| >=2cm | 59 (61) |
| Nodal status | |
| Positive | 55 (56) |
| Negative | 43 (44) |
| Chemotherapy regimen | |
| AC$ | 45 (46) |
| Other | 53 (54) |
| Hormonal Therapy Initiated | |
| Yes | 53 (87) |
| No | 8 (13) |
| Hormone Treatment | |
| Tamoxifen | 29 (59) |
| Aromatase Inhibitor | 20 (41) |
| Radiation Therapy | |
| Yes | 66 (67) |
| No | 32 (33) |
| Behavioral | |
| Self-efficacy, Mean (SD) | 71.7 (5.5) |
| Adherence determinants scale, Mean (SD) | 7.96 (0.32) |
| Perceived severity subscale | 3.99 (0.10) |
| Perceived susceptibility subscale | 14.33 (2.41) |
| Anthropometric | |
| Weight (in lbs), Mean (SD) | 176.27 (38.82) |
| BMI (kg/m2), Mean (SD) | 29.66 (6.37) |
| Normal | 23 (23) |
| Overweight/Obese | 75 (77) |